サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427707

自閉症スペクトラム障害治療の世界市場レポート2024

Autism Spectrum Disorders Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
自閉症スペクトラム障害治療の世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

自閉症スペクトラム障害治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.6%の年間複合成長率（CAGR）で37億3,000万米ドルに成長すると予想されます。自閉症スペクトラム障害（ASD）の有病率の増加、保険適用範囲の拡大、治療におけるテクノロジーの統合、および世界の共同調査の取り組みにより、予測期間の成長が予想されます。予測期間中に予想される主な動向には、早期介入戦略の導入、人工知能（AI）の統合、親と介護者向けの研修プログラム、薬理学的介入、学校ベースおよび教育的介入が含まれます。

自閉症スペクトラム障害（ASD）の急増は、近い将来、自閉症スペクトラム障害市場拡大の重要な原動力となると予想されます。 ASDには、社会的相互作用やコミュニケーションスキルにおける課題を特徴とするさまざまな状態が含まれます。 ASDを持つ子供たちの特定が増えていることは、この人口統計に合わせた多様な治療選択肢の開発を促進する上で極めて重要な役割を果たしています。たとえば、疾病管理予防センター（CDC）の2021年のデータによると、米国では8歳の子ども38人に1人が自閉症スペクトラム障害と診断されており、男子の有病率は女子の3.8倍となっています。さらに、8歳未満の子供のASDの有病率は2.8%であることが指摘されています。このASDの蔓延の拡大により、自閉症スペクトラム障害治療市場の成長が促進されると予想されます。

ヘルスケア支出の増加が、自閉症スペクトラム障害治療市場の成長を促進する重要な要因として浮上しています。 ASD調査に割り当てられる資金の増加は、早期介入プログラムの実施とヘルスケア保険の範囲内へのASD治療の組み込みと相まって、市場拡大において極めて重要な役割を果たしています。例えば、メディケア＆メディケイド・サービスセンター（CMS）が2023年6月に発表したデータによると、米国の国民医療費は2.7％急増し、2021年には4兆3,000億米ドルに達し、1人当たり12,914米ドルに達し、国内総生産（GDP）の18.3％を占めることが明らかになりました。その結果、医療費の増加は自閉症スペクトラム障害治療市場の成長を促進する原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の自閉症スペクトラム障害治療市場、薬物療法別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 抗精神病薬
  • SSRI/抗うつ薬
  • 覚醒剤
  • 睡眠薬
  • その他の薬物療法
  • 世界の自閉症スペクトラム障害治療市場、治療アプローチ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 行動的アプローチ
  • 早期介入
  • 薬剤
  • 世界の自閉症スペクトラム障害治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 自閉症障害
  • アスペルガー症候群
  • 広汎性発達障害
  • その他の用途
  • 世界の自閉症スペクトラム障害治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • ドラッグストアおよび小売薬局
  • オンライン薬局

第7章 地域および国の分析

  • 世界の自閉症スペクトラム障害治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の自閉症スペクトラム障害治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 自閉症スペクトラム障害治療市場の競合情勢
  • 自閉症スペクトラム障害治療市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson Services Inc.
    • Roche Holding AG
    • Novartis AG
    • Bristol-Myers Squibb

第31章 その他の大手および革新的な企業

  • Teva Pharmaceuticals Industries Ltd.
  • Otsuka Pharmaceutical Co.Ltd.
  • Zenotech Laboratories Limited
  • Jazz Pharmaceuticals plc
  • Alembic Pharmaceuticals Limited
  • 4D Pharma plc
  • Acadia Pharmaceuticals Inc.
  • Impel Pharmaceuticals Inc
  • Enterin Inc.
  • Cognoa
  • BrainStorm Cell Therapeutics Inc.
  • Axial Therapeutics Inc.
  • Neurim Pharmaceuticals Inc.
  • Curemark LLC
  • Yamo Pharmaceuticals LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13551

Autism spectrum disorder (ASD) treatment encompasses various therapeutic interventions aimed at addressing the neurodevelopmental challenges in communication, behavior, and social interaction. The treatment modalities include behavior therapy, speech-language therapy, and play-based therapy, all designed to enhance speech and language skills.

The primary therapeutic approaches in autism spectrum disorder treatment involve the use of pharmaceuticals such as antipsychotic drugs, SSRIs or antidepressants, stimulants, sleep medications, and other drug therapies. Antipsychotic drugs are specifically employed to alleviate symptoms associated with schizophrenia and other psychotic conditions. The comprehensive treatment of autism spectrum disorders incorporates behavioral strategies, early intervention, and medication targeting specific conditions such as autistic disorder, Asperger syndrome, pervasive developmental disorder, among others. These treatment products are distributed through hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

The autism spectrum disorders treatment market research report is one of a series of new reports from The Business Research Company that provides autism spectrum disorders treatment market statistics, including the autism spectrum disorders treatment industry's global market size, regional shares, competitors with an autism spectrum disorders treatment market share, detailed autism spectrum disorders treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the autism spectrum disorders treatment industry. This autism spectrum disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The autism spectrum disorders treatment market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.89 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historical period is attributed to heightened awareness and improved diagnostic practices, advancements in therapeutic approaches, supportive government initiatives, advocacy efforts by parents and caregivers, and increased involvement of the educational system.

The autism spectrum disorders treatment market size is expected to see strong growth in the next few years. It will grow to $3.73 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period is expected due to the increasing prevalence of Autism Spectrum Disorder (ASD), broader insurance coverage, the integration of technology in therapies, and global collaborative research efforts. Major trends anticipated in the forecast period include the implementation of early intervention strategies, the integration of Artificial Intelligence (AI), training programs for parents and caregivers, pharmacological interventions, and school-based and educational interventions.

The burgeoning prevalence of autism spectrum disorders (ASD) is expected to be a significant driving force behind the expansion of the autism spectrum disorders market in the foreseeable future. ASD encompasses a range of conditions characterized by challenges in social interaction and communication skills. The increasing identification of children with ASDs plays a pivotal role in driving the development of diverse treatment options tailored for this demographic. For instance, as per data from the Centers for Disease Control and Prevention (CDC) in 2021, one in 38 children aged eight years was diagnosed with autism spectrum disorders in the USA, with boys exhibiting 3.8 times higher prevalence than girls. Moreover, the prevalence of ASDs among children under 8 years was noted at 2.8%. This escalating prevalence of ASDs is anticipated to fuel growth within the autism spectrum disorders treatment market.

Rising healthcare expenditure emerges as a significant contributor propelling the growth of the autism spectrum disorders treatment market. The increase in funding allocated for ASD research, coupled with the implementation of early intervention programs and the incorporation of ASD therapies within healthcare coverage, plays a pivotal role in market expansion. For instance, data released by the Centers for Medicare & Medicaid Services (CMS) in June 2023 highlighted that the national health expenditure in the United States surged by 2.7% to reach $4.3 trillion in 2021, amounting to $12,914 per person and accounting for 18.3% of the Gross Domestic Product (GDP). Consequently, the escalating healthcare expenditure serves as a driving force propelling growth within the autism spectrum disorders treatment market.

Technology innovation within the autism spectrum disorders market has become a prominent trend. Researchers are directing their efforts toward pioneering advancements in the behavioral analysis of autism patients, aiming to cultivate social and occupational skills among children with autism. An illustration of this trend is evident in BrainCo Inc's December 2021 introduction of an innovative autism intervention method. This method leverages brain-computer interface technology, undergoing clinical trials in collaboration with the China Autism Rehabilitation Center, Shanghai Children's Hospital, and Beijing Children's Hospital. Combining a non-invasive EEG headband with computer-based games and exercises, this approach enables therapists to discern real-time brain activity patterns, monitor progress through interactions, and analyze facial expressions via eye contact observations.

Key players in the autism spectrum disorders treatment market are actively incorporating artificial intelligence (AI) to expedite and enhance the diagnosis of autism spectrum disorders. An example of this strategy is witnessed in Cognoa's initiative in June 2021. This US-based artificial intelligence developer introduced an algorithm specifically designed to aid clinicians in swiftly and accurately diagnosing autism in young children. The software operates by collating information obtained from parent, physician, and home video questionnaires, enabling it to provide recommendations to pediatricians for diagnosing patients.

In December 2022, MBF Healthcare Partners II, L.P., a healthcare-focused middle-market private equity firm based in the United States, successfully acquired ABA Connect for an undisclosed sum. Through this acquisition, MBF Healthcare Partners II, L.P., aims to broaden ABA Connect's services, extending support to children and families across Texas and other states in the USA. ABA Connect, a US-based provider of applied behavior analysis, utilizes evidence-based principles to improve the quality of life for children and families affected by autism spectrum disorders.

Major companies operating in the autism spectrum disorders treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Novartis AG, Bristol-Myers Squibb, Teva Pharmaceuticals Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Zenotech Laboratories Limited, Jazz Pharmaceuticals PLC, Alembic Pharmaceuticals Limited, 4D Pharma PLC, Acadia Pharmaceuticals Inc., Impel Pharmaceuticals Inc., Enterin Inc., Cognoa, BrainStorm Cell Therapeutics Inc., Axial Therapeutics Inc., Neurim Pharmaceuticals Inc., Curemark LLC, Yamo Pharmaceuticals LLC, Zynerba Pharmaceuticals Inc., Pax Medica, Stalicla SA, Neurotech International Limited, Confluence Pharmaceuticals LLC, MapLight Therapeutics Inc., SciSparc Ltd., Q BioMed Inc., Mercy Care, IAMA Therapeutics

North America was the largest region in the autism spectrum disorders treatment market in 2023. The regions covered in the autism spectrum disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the autism spectrum disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The autism spectrum disorders treatment market involves revenues earned by entities by providing therapies, assistive technologies, behavioral interventions, and education programs for treating and managing autism spectrum disorders (ASD). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autism Spectrum Disorders Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autism spectrum disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autism spectrum disorders treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autism spectrum disorders treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Therapy: Antipsychotic Drugs; SSRIs or Antidepressants; Stimulants; Sleep Medications; Other Drug Therapies
  • 2) By Treatment Approach: Behavioral Approaches; Early Intervention; Medication
  • 3) By Application: Autistic Disorder; Asperger Syndrome; Pervasive Developmental Disorder; Other Applications
  • 4) By Distribution Channel: Hospital Pharmacies; Drug Stores and Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Roche Holding AG; Novartis AG; Bristol-Myers Squibb
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autism Spectrum Disorders Treatment Market Characteristics

3. Autism Spectrum Disorders Treatment Market Trends And Strategies

4. Autism Spectrum Disorders Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Autism Spectrum Disorders Treatment Market Size and Growth

  • 5.1. Global Autism Spectrum Disorders Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Autism Spectrum Disorders Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Autism Spectrum Disorders Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Autism Spectrum Disorders Treatment Market Segmentation

  • 6.1. Global Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antipsychotic Drugs
  • SSRIs/Antidepressants
  • Stimulants
  • Sleep Medications
  • Other Drug Therapies
  • 6.2. Global Autism Spectrum Disorders Treatment Market, Segmentation By Treatment Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Behavioral Approaches
  • Early Intervention
  • Medication
  • 6.3. Global Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Other Applications
  • 6.4. Global Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

7. Autism Spectrum Disorders Treatment Market Regional And Country Analysis

  • 7.1. Global Autism Spectrum Disorders Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Autism Spectrum Disorders Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Autism Spectrum Disorders Treatment Market

  • 8.1. Asia-Pacific Autism Spectrum Disorders Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Autism Spectrum Disorders Treatment Market

  • 9.1. China Autism Spectrum Disorders Treatment Market Overview
  • 9.2. China Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Autism Spectrum Disorders Treatment Market

  • 10.1. India Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Autism Spectrum Disorders Treatment Market

  • 11.1. Japan Autism Spectrum Disorders Treatment Market Overview
  • 11.2. Japan Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Autism Spectrum Disorders Treatment Market

  • 12.1. Australia Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Autism Spectrum Disorders Treatment Market

  • 13.1. Indonesia Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Autism Spectrum Disorders Treatment Market

  • 14.1. South Korea Autism Spectrum Disorders Treatment Market Overview
  • 14.2. South Korea Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Autism Spectrum Disorders Treatment Market

  • 15.1. Western Europe Autism Spectrum Disorders Treatment Market Overview
  • 15.2. Western Europe Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Autism Spectrum Disorders Treatment Market

  • 16.1. UK Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Autism Spectrum Disorders Treatment Market

  • 17.1. Germany Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Autism Spectrum Disorders Treatment Market

  • 18.1. France Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Autism Spectrum Disorders Treatment Market

  • 19.1. Italy Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Autism Spectrum Disorders Treatment Market

  • 20.1. Spain Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Autism Spectrum Disorders Treatment Market

  • 21.1. Eastern Europe Autism Spectrum Disorders Treatment Market Overview
  • 21.2. Eastern Europe Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Autism Spectrum Disorders Treatment Market

  • 22.1. Russia Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Autism Spectrum Disorders Treatment Market

  • 23.1. North America Autism Spectrum Disorders Treatment Market Overview
  • 23.2. North America Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Autism Spectrum Disorders Treatment Market

  • 24.1. USA Autism Spectrum Disorders Treatment Market Overview
  • 24.2. USA Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Autism Spectrum Disorders Treatment Market

  • 25.1. Canada Autism Spectrum Disorders Treatment Market Overview
  • 25.2. Canada Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Autism Spectrum Disorders Treatment Market

  • 26.1. South America Autism Spectrum Disorders Treatment Market Overview
  • 26.2. South America Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Autism Spectrum Disorders Treatment Market

  • 27.1. Brazil Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Autism Spectrum Disorders Treatment Market

  • 28.1. Middle East Autism Spectrum Disorders Treatment Market Overview
  • 28.2. Middle East Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Autism Spectrum Disorders Treatment Market

  • 29.1. Africa Autism Spectrum Disorders Treatment Market Overview
  • 29.2. Africa Autism Spectrum Disorders Treatment Market, Segmentation By Drug Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Autism Spectrum Disorders Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Autism Spectrum Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Autism Spectrum Disorders Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Autism Spectrum Disorders Treatment Market Competitive Landscape
  • 30.2. Autism Spectrum Disorders Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Autism Spectrum Disorders Treatment Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceuticals Industries Ltd.
  • 31.2. Otsuka Pharmaceutical Co.Ltd.
  • 31.3. Zenotech Laboratories Limited
  • 31.4. Jazz Pharmaceuticals plc
  • 31.5. Alembic Pharmaceuticals Limited
  • 31.6. 4D Pharma plc
  • 31.7. Acadia Pharmaceuticals Inc.
  • 31.8. Impel Pharmaceuticals Inc
  • 31.9. Enterin Inc.
  • 31.10. Cognoa
  • 31.11. BrainStorm Cell Therapeutics Inc.
  • 31.12. Axial Therapeutics Inc.
  • 31.13. Neurim Pharmaceuticals Inc.
  • 31.14. Curemark LLC
  • 31.15. Yamo Pharmaceuticals LLC

32. Global Autism Spectrum Disorders Treatment Market Competitive Benchmarking

33. Global Autism Spectrum Disorders Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Autism Spectrum Disorders Treatment Market

35. Autism Spectrum Disorders Treatment Market Future Outlook and Potential Analysis

  • 35.1 Autism Spectrum Disorders Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Autism Spectrum Disorders Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Autism Spectrum Disorders Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer